STE
STERIS plcNYSEHealthcare$218.71-0.56%ClosedMarket Cap: $21.47B
As of 2026-04-06
Valuation
P/E (TTM)
30.33
PEG
0.59
P/B
3.02
P/S
3.70
EV/EBITDA
17.04
DCF Value
$117.35
FCF Yield
4.2%
Div Yield
1.1%
Margins & Returns
Gross Margin
44.1%
Operating Margin
17.2%
Net Margin
12.1%
ROE
10.2%
ROA
6.7%
ROIC
7.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $1.50B | 43.8% | $271.0M | $192.8M | $1.96 | $0.63 |
| Q2 2026 | $1.46B | 44.2% | $268.0M | $191.9M | $1.94 | $0.63 |
| Q1 2026 | $1.39B | 45.1% | $246.0M | $177.4M | $1.79 | $0.57 |
| Q4 2025 | $1.48B | 43.3% | $216.2M | $145.7M | $1.48 | $0.57 |
| FY 2025 | $5.46B | 44.0% | $866.6M | $614.6M | $6.20 | $2.23 |
| Q3 2025 | $1.37B | 44.5% | $245.3M | $173.5M | $1.75 | $0.57 |
| Q2 2025 | $1.33B | 43.6% | $219.7M | $150.0M | $1.51 | $0.57 |
| Q1 2025 | $1.28B | 44.7% | $185.5M | $145.4M | $1.46 | $0.52 |
| Q4 2024 | $1.12B | 40.2% | $245.2M | $-1.4M | $-0.01 | $0.52 |
| FY 2024 | $5.14B | 43.2% | $836.1M | $378.2M | $3.81 | $2.03 |
| Q3 2024 | $1.30B | 43.2% | $226.5M | $140.7M | $1.42 | $0.52 |
| Q2 2024 | $1.24B | 44.1% | $191.6M | $115.3M | $1.16 | $0.52 |